Maintenance fees coming due

Crititech, Inc.

10 maintenance fees come due in the 12 months from Nov 14, 2026, the next on Feb 27, 2027. Unpaid by Aug 27, 2027, that one lapses early.

A maintenance fee does not end a patent on its due date. It falls due at 3.5, 7.5 and 11.5 years from grant, and the patent lapses only if the fee is still unpaid at the end of the six month grace period that follows.

Patent	Title	Holder	Status	Fee due	Lapses if unpaid	Expires	Confidence
US 10,391,090	Methods for Solid Tumor Treatment Crititech, Inc. In force Fee due Feb 27, 2027 Lapses if unpaid Aug 27, 2027 Term ends Jun 6, 2036 · High confidence	Crititech, Inc.	In force	Feb 27, 2027	Aug 27, 2027	Term ends Jun 6, 2036	High confidence
US 11,737,972	Treatment of Epithelial Cysts by Intracystic Injection of Antineoplastic Particles Crititech, Inc. In force Fee due Feb 28, 2027 Lapses if unpaid Aug 30, 2027 Ends no later than Jun 8, 2038 · Medium confidence	Crititech, Inc.	In force	Feb 28, 2027	Aug 30, 2027	Ends no later than Jun 8, 2038	Medium confidence
US 11,738,014	Niraparib particles and uses thereof Crititech, Inc. In force Fee due Feb 28, 2027 Lapses if unpaid Aug 30, 2027 Term ends Nov 8, 2042 · High confidence	Crititech, Inc.	In force	Feb 28, 2027	Aug 30, 2027	Term ends Nov 8, 2042	High confidence
US 11,738,029	Rucaparib particles and uses thereof Crititech, Inc. In force Fee due Feb 28, 2027 Lapses if unpaid Aug 30, 2027 Term ends Nov 8, 2042 · High confidence	Crititech, Inc.	In force	Feb 28, 2027	Aug 30, 2027	Term ends Nov 8, 2042	High confidence
US 10,398,646	Methods for Treating Lung Disorders Crititech, Inc. In force Fee due Mar 3, 2027 Lapses if unpaid Sep 3, 2027 Term ends Jun 13, 2038 · High confidence	Crititech, Inc.	In force	Mar 3, 2027	Sep 3, 2027	Term ends Jun 13, 2038	High confidence
US 10,507,181	Methods for Treating Lung Disorders Crititech, Inc. In force Fee due Jun 17, 2027 Lapses if unpaid Dec 17, 2027 Term ends Jun 13, 2038 · High confidence	Crititech, Inc.	In force	Jun 17, 2027	Dec 17, 2027	Term ends Jun 13, 2038	High confidence
US 10,507,195	Taxane Particles and Their Use Crititech, Inc. In force Fee due Jun 17, 2027 Lapses if unpaid Dec 17, 2027 Term ends Jun 6, 2036 · High confidence	Crititech, Inc.	In force	Jun 17, 2027	Dec 17, 2027	Term ends Jun 6, 2036	High confidence
US 9,233,348	Equipment Assembly for and Method of Processing Particles Crititech, Inc. In force Fee due Jul 12, 2027 Lapses if unpaid Jan 12, 2028 Term ends Jun 6, 2033 · High confidence	Crititech, Inc.	In force	Jul 12, 2027	Jan 12, 2028	Term ends Jun 6, 2033	High confidence
US 11,918,691	Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancer Crititech, Inc. In force Fee due Sep 5, 2027 Lapses if unpaid Mar 6, 2028 Ends no later than Oct 3, 2038 · Medium confidence	Crititech, Inc.	In force	Sep 5, 2027	Mar 6, 2028	Ends no later than Oct 3, 2038	Medium confidence
US 11,931,368	Glucocorticoid "Nintedanib" Particles and Their Use Crititech, Inc. In force Fee due Sep 19, 2027 Lapses if unpaid Mar 20, 2028 Term ends Dec 9, 2038 · High confidence	Crititech, Inc.	In force	Sep 19, 2027	Mar 20, 2028	Term ends Dec 9, 2038	High confidence

10 of 10 patents shown. Soonest fee due date first, then patent number.

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.